HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shoulder Dislocation (Dislocation, Shoulder)

Displacement of the HUMERUS from the SCAPULA.
Also Known As:
Dislocation, Shoulder; Glenohumeral Subluxation; Dislocation, Glenohumeral; Dislocations, Glenohumeral; Dislocations, Shoulder; Glenohumeral Dislocations; Glenohumeral Subluxations; Shoulder Dislocations; Subluxation, Glenohumeral; Subluxations, Glenohumeral; Glenohumeral Dislocation
Networked: 500 relevant articles (35 outcomes, 60 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pain (Aches)
2. Rotator Cuff Injuries
3. Wounds and Injuries (Trauma)
4. Unconsciousness (Loss of Consciousness)
5. Joint Diseases (Joint Disease)

Experts

1. Edwards, T Bradley: 5 articles (02/2017 - 08/2003)
2. Debski, Richard E: 5 articles (06/2013 - 07/2002)
3. McMahon, Patrick J: 4 articles (06/2013 - 05/2003)
4. Zhao, Jinzhong: 3 articles (03/2021 - 12/2020)
5. Itoi, Eiji: 3 articles (03/2017 - 03/2010)
6. Sano, Hirotaka: 3 articles (03/2017 - 03/2010)
7. Yamamoto, Nobuyuki: 3 articles (03/2017 - 03/2010)
8. Walch, Gilles: 3 articles (02/2017 - 08/2003)
9. Andreoli, Carlos Vicente: 3 articles (03/2016 - 10/2014)
10. Belangero, Paulo Santoro: 3 articles (03/2016 - 10/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Shoulder Dislocation:
1. Lidocaine (Xylocaine)FDA LinkGeneric
2. Capsules (Microcapsules)IBA
3. Hypnotics and Sedatives (Sedatives)IBA
4. BenzodiazepinesIBA
08/01/2008 - "The aim was to determine if intraarticular lidocaine (IAL) injection is as effective as IV procedural sedation with narcotics and benzodiazepines for reduction of anterior shoulder dislocations. "
02/01/2015 - "The list of level A recommendations includes: 1) use of IV acetaminophen for opioid sparing properties and reduction of opioid related adverse events; 2) ketamine-midazolam combination preferred over fentanyl-midazolam fentanyl-propofol in pediatric patients; 3) boluses of ketamine IV (particularly in the population under the age of 2 years and over the age of 13) can lead to impairment of the upper airways, including the onset of laryngospasm, requiring specific expertise and skills for administration; 4) the use of ketamine increases the potential risk of psychomotor agitation, which can happen in up to 30% of adult patients (this peculiar side effect can be significantly reduced by concomitant systemic use of benzodiazepines); 5) for shoulder dislocations and fractures of the upper limbs, the performance of brachial plexus block reduces the time spent in ED compared to sedation; 6) pain relief and the use of opioids in patients with acute abdominal pain do not increase the risk of error in the diagnostic and therapeutic pathway in adults; 7) in newborns, the administration of sucrose reduces behavioural responses to blood sampling from a heel puncture; 8) in newborns, breastfeeding or formula feeding during the procedure reduces the measures of distress; 9) in pediatric patients, non-pharmacological techniques such as distraction, hypnosis and cognitive-behavioural interventions reduce procedural pain caused by the use of needles; 10) in pediatric patients, preventive application of eutectic mixtures of prilocaine and lidocaine allows arterial and venous samples to be taken in optimum conditions; 11) in pediatric patients, the combination of hypnotics (midazolam) and N2O is effective for procedural pain, but may be accompanied by loss of consciousness. "
5. Midazolam (Versed)FDA LinkGeneric
6. Fentanyl (Sublimaze)FDA LinkGeneric
7. KetamineFDA LinkGeneric
02/01/2013 - "A second patient underwent ketamine sedation for reduction of a shoulder dislocation. "
03/01/2021 - "We describe 4 patients who presented to the emergency department with acute traumatic painful conditions (one patellar dislocation, one shoulder dislocation, and two forearm fractures) and received nebulized ketamine for management of their pain. "
01/01/2021 - "Clinical Efficacy of Dexmedetomidine versus Ketamine in Shoulder Dislocation Reduction: A Randomized Clinical Trial Study."
02/01/2015 - "The list of level A recommendations includes: 1) use of IV acetaminophen for opioid sparing properties and reduction of opioid related adverse events; 2) ketamine-midazolam combination preferred over fentanyl-midazolam fentanyl-propofol in pediatric patients; 3) boluses of ketamine IV (particularly in the population under the age of 2 years and over the age of 13) can lead to impairment of the upper airways, including the onset of laryngospasm, requiring specific expertise and skills for administration; 4) the use of ketamine increases the potential risk of psychomotor agitation, which can happen in up to 30% of adult patients (this peculiar side effect can be significantly reduced by concomitant systemic use of benzodiazepines); 5) for shoulder dislocations and fractures of the upper limbs, the performance of brachial plexus block reduces the time spent in ED compared to sedation; 6) pain relief and the use of opioids in patients with acute abdominal pain do not increase the risk of error in the diagnostic and therapeutic pathway in adults; 7) in newborns, the administration of sucrose reduces behavioural responses to blood sampling from a heel puncture; 8) in newborns, breastfeeding or formula feeding during the procedure reduces the measures of distress; 9) in pediatric patients, non-pharmacological techniques such as distraction, hypnosis and cognitive-behavioural interventions reduce procedural pain caused by the use of needles; 10) in pediatric patients, preventive application of eutectic mixtures of prilocaine and lidocaine allows arterial and venous samples to be taken in optimum conditions; 11) in pediatric patients, the combination of hypnotics (midazolam) and N2O is effective for procedural pain, but may be accompanied by loss of consciousness. "
8. Propofol (Diprivan)FDA LinkGeneric
9. PlasticsIBA
10. Narcotics (Narcotic Analgesics)IBA

Therapies and Procedures

1. Analgesia
2. Conservative Treatment
3. Arthroplasty
4. Anesthesia
5. Therapeutics